Stuart J. Thomson
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Research top 5%
Papers in
- Oncology 13
- HER2/EGFR in Cancer Research 4
-
- Ubiquitin and proteasome pathways 10
- Protein Degradation and Inhibitors 4
- Genomics and Chromatin Dynamics 4
- Co-authors
- Louis C. Mahadevan (7 shared papers)John D. Haley (10 shared papers)Alison L. Clayton (3 shared papers)Filippo Petti (5 shared papers)Neil W. Gibson (4 shared papers)Kenneth K. Iwata (5 shared papers)Elizabeth A. Buck (5 shared papers)David Mark Epstein (5 shared papers)
- Journals
- Clinical & Experimental Metastasis (4 papers)Cancer Research (3 papers)Molecular Cell (3 papers)Clinical Biochemistry (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Stuart J. Thomson
55 papers receiving 4.5k citations
Stuart J. Thomson's Hit Papers
Peers
Comparison fields: 5 of 153
- Oncology 1.2k
- Cancer Research 558
- Molecular Biology 2.6k
- Pulmonary and Respiratory Medicine 716
- Cell Biology 343
Countries citing papers authored by Stuart J. Thomson
This map shows the geographic impact of Stuart J. Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Thomson more than expected).
Fields of papers citing papers by Stuart J. Thomson
This network shows the impact of papers produced by Stuart J. Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Thomson. The network helps show where Stuart J. Thomson may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart J. Thomson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 564 | |
| 2 | 2003 | 419 | |
| 3 | 1999 | 394 | |
| 4 | 2006 | 370 | |
| 5 | Targeting the p300/CBP Axis in Lethal Prostate Cancer Hit paper breakdown → | 2021 | 215 |
| 6 | 2005 | 195 | |
| 7 | 1999 | 193 | |
| 8 | 2010 | 188 | |
| 9 | 2008 | 175 | |
| 10 | 2001 | 174 | |
| 11 | 2008 | 173 | |
| 12 | 2008 | 164 | |
| 13 | 1996 | 152 | |
| 14 | 2001 | 116 | |
| 15 | 2003 | 104 | |
| 16 | 2005 | 91 | |
| 17 | 1995 | 87 | |
| 18 | 2001 | 85 | |
| 19 | 2003 | 76 | |
| 20 | 2004 | 65 |
About Stuart J. Thomson
Stuart J. Thomson is a scholar working on Oncology, Molecular Biology, Inorganic Chemistry, Condensed Matter Physics and Waste Management and Disposal, having authored 59 papers that have together received 4.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Micro and Nano Robotics (5 papers), Lung Cancer Treatments and Mutations (5 papers), Zeolite Catalysis and Synthesis (4 papers), Protein Degradation and Inhibitors (4 papers), Genomics and Chromatin Dynamics (4 papers), HER2/EGFR in Cancer Research (4 papers) and Chemical Synthesis and Characterization (4 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (558 citations), Molecular Biology (2.6k citations), Pulmonary and Respiratory Medicine (716 citations) and Cell Biology (343 citations). Stuart J. Thomson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Louis C. Mahadevan, John D. Haley, Alison L. Clayton, Filippo Petti, Neil W. Gibson, Kenneth K. Iwata, Elizabeth A. Buck, David Mark Epstein, Eric Brown and Catherine A. Hazzalin. Their work appears in journals such as Clinical & Experimental Metastasis, Cancer Research, Molecular Cell, Clinical Biochemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.